Mast Therapeutics, Inc.

Mast Therapeutics, Inc.

Biotechnology Research 5 employees
Employees
5
Contacts
1
Emails
1
Phones
1

Mast Therapeutics, Inc. Overview

Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
5
Founded
1995
Funding
15.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Mast Therapeutics, Inc.

We are a biopharmaceutical company focused on developing therapies for serious or life-threatening diseases. Through our acquisition of SynthRx, Inc. in 2011, we acquired our Membrane Adhesion & Sealant Technology (MAST) platform, which includes proprietary poloxamer-related data and know-how derived from over two decades of clinical, nonclinical and manufacturing experience, and we are leveraging the MAST platform to develop MST-188 for diseases and conditions characterized by microcirculatory insufficiency.

Mast Therapeutics, Inc. Contact Details

People in AeroLeads
3
With contact data
1
Email contacts
1
33.3% coverage
Phone contacts
1
33.3% coverage

Mast Therapeutics, Inc. Org Chart

Sample employees and titles
Name Title Contact
Ruthie Musquiz Siska Clinical Rn Site Liaison for Research at Global Blood Therapeutics
Email Phone
Masud Islam Managing Director at Mast Therapeutics, Inc.
View
Solanki Mehul Any at Mast Therapeutics, Inc.
View

Employees by Management Level

Director 2 profiles
Individual contributor 2 profiles
Manager 1 profile
Senior / Lead 1 profile

Compare Similar Companies to Mast Therapeutics, Inc.